Combining HD-tDCS and iTBS in Treating Negative Symptoms of Schizophrenia

Enrolling by invitation · Not applicable · Has a placebo group

Conditions studied: Negative Symptoms in Schizophrenia, Brain Stimulation Intervention

In brief

Dysfunction of the dorsolateral prefrontal cortex (DLPFC) is central to the persistence of negative symptoms in schizophrenia. Both HD-tDCS and iTBS targeting the left DLPFC have shown therapeutic benefit. This trial will test the hypothesis that combining HD-tDCS with iTBS yields additive efficacy.

Key facts

Study ID
NCT07680959
Run by
Tri-Service General Hospital (TSGH)
People needed
100
Starts
2024-05-06
Expected to finish
2028-03-01
Last updated by the study team
2026-07-09

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.